Shichao Ai

Shichao Ai

Auto-generated profile, based on publicly available information

Shichao Ai

Division of Gastric Surgery, Department of General Surgery, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing 210008, Jiangsu Province, China.

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Biomaterials
Verified
Journal Article
Closed access
Zhengyang YangZhengyang Yang
Zhengyang Yang
JWJiafeng Wang
Jiafeng Wang
SLSong Liu
Song Liu
XLXianghui Li
Xianghui Li
LMLeiying Miao
Leiying Miao
WGWenxian GUAN
Wenxian GUAN

28 October 2021 in RSC Advances
Verified
Journal Article
Open access
PDF file
XLXianghui Li
Xianghui Li
SAShichao Ai
Shichao Ai
XLXiaofeng Lu
Xiaofeng Lu
SLSong Liu
Song Liu
WGWenxian GUAN
Wenxian GUAN
Nanoparticles designed for gastric cancer theronostics.

9 September 2021 in World Journal of Surgical Oncology
Verified
Journal Article
Open access
PDF file
XLXiaofeng Lu
Xiaofeng Lu
SLSong Liu
Song Liu
XXXuefeng Xia
Xuefeng Xia
FSFeng Sun
Feng Sun
ZLZhijian Liu
Zhijian Liu
WGWenxian GUAN
Wenxian GUAN
Background: The safety and efficacy of indocyanine green (ICG) imaging navigational laparoscopic gastrectomy remain controversial. This study is to evaluate the short-term and long-term outcomes of ICG-guided laparoscopic radial gastrectomy in patients with gastric cancer. Methods: Consecutive patients with definitive diagnosis of gastric cancer that underwent laparoscopic radical gastrectomy were collected retrospectively. Propensity score matching (PSM) at 1:1 ratio was performed to compare the outcomes of two groups. Results: A total of 122 qualified patients were divided into ICG group (n = 34) and non-ICG group (n = 88). PSM yielded 28 patients with comparable baseline characteristics into each group. The number of retrieved lymph node in ICG group was significantly higher than that in non-ICG group (P = 0.0196). There was no statistical difference of perioperative, short-term, and long-term complications between the two groups. Conclusion: ICG-guided laparoscopic radical gastrectomy is safe and effective, and ICG-navigated lymphadenectomy improves the number of retrieved lymph nodes for patients with gastric cancer.

30 May 2019 in Particle & Particle Systems Characterization
Verified
Journal Article
Closed access
PDF file
Zhengyang YangZhengyang Yang
Zhengyang Yang
JWJiafeng Wang
Jiafeng Wang
SLSong Liu
Song Liu
FSFeng Sun
Feng Sun
JMJi Miao
Ji Miao
WGWenxian GUAN
Wenxian GUAN

22 November 2022 in Cancers
Verified
Journal Article
Open access
PDF file
ZLZhiyan Li
Zhiyan Li
XLXianghui Li
Xianghui Li
XZXudong Zhu
Xudong Zhu
SAShichao Ai
Shichao Ai
WGWenxian GUAN
Wenxian GUAN
SLSong Liu
Song Liu
The treatment of gastric cancer mainly depends on radical gastrectomy. Determination of appropriate surgical margins and adequate lymph node (LN) resection are two major surgical steps that directly correlate with prognosis in gastric cancer. Due to the expanding use of minimally invasive procedures, it is no longer possible to locate tumors and LNs through touch. As an alternative, tracers have begun to enter the field due to their capacities for intraoperative visualization. Herein, we summarize the application of contemporary tracers in gastric cancer surgery, including isosulfan blue, methylene blue, patent blue, indocyanine green, carbon particles, and radioactive tracers. Their mechanisms, administration methods, detection efficiency, and challenges, as well as perspectives on them, are also outlined.

1 July 2025 in BMC Gastroenterology
Verified
Journal Article
Open access
PDF file
YSYiwen Sun
Yiwen Sun
MLMengjie Liang
Mengjie Liang
XWXingzhou Wang
Xingzhou Wang
WDWenting Dong
Wenting Dong
ZWZhenShui Wu
ZhenShui Wu
WGWenxian Guan
Wenxian Guan
Metabolism plays an important role in the occurrence and development of gastric cancer, including in neoadjuvant immunochemotherapy. However, whether nutrition-related indicators can predict the efficacy of neoadjuvant immunochemotherapy and the prognosis of gastric cancer patients has not been addressed. This study systematically screens various nutritional indicators to explore their efficacy in predicting responses to neoadjuvant immunochemotherapy and patients’ prognosis in locally advanced gastric cancer (LAGC). We retrospectively analyzed 134 LAGC patients who underwent radical resection after neoadjuvant immunochemotherapy. According to postoperative tumor regression grade (TRG), these patients were divided into good responder group (TRG1-0) and poor responder group (TRG3-2) (AJCC/CAP guidelines). Inflammatory and/or nutritional markers were compared for their efficacy on predicting patients’ pathological tumor regression response. The univariate and multivariate logistic regression were carried out to identify the independent factors for predicting pathological tumor regression response, and a predictive nomogram model was further established. Among the total 134 LAGC patients, tumor specimens from 71 and 63 patients had TRG1-0 and TRG3-2 tumor responses, respectively. Multivariate analysis showed that controlling nutritional status (CONUT) score and nutrition risk screening 2002 (NRS2002) score were independent predictors of pathological tumor regression response (OR, 0.68; 95% CI, 0.50–0.91; P = 0.010 and OR, 0.66; 95% CI, 0.45–0.96; P = 0.031, respectively). With the use of ROC curve analysis, the optimal critical level of CONUT score and NRS2002 score were both 3. The CONUT-NRS2002 combined score was constructed. Patients with lower CONUT-NRS2002 had a better pathological response than those with higher CONUT-NRS2002 (P = 0.003). Moreover, Patients with higher CONUT-NRS2002 scores had poorer prognosis (P < 0.05). The nomogram based on CONUT score and NRS2002 score demonstrated good predictive ability and clinical application value. CONUT score and NRS2002 score are independent factors of pathological tumor regression response in LAGC patients after neoadjuvant immunochemotherapy. The constructed CONUT-NRS2002 combined score has a good potential in predicting pathological tumor regression response and prognosis of LAGC patients after neoadjuvant immunochemotherapy, serving as a new predictive indicator.